Skip to main content
Equibles

Candriam S.C.A.

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1537014 STRASSEN, N4
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$31,370,412
+$17,448,798 QoQ
Shares Held
1,707,698
+139.9% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#22
of 215 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. VRDN ranks #24 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 195,674 $122,010,565
2 RVMD
Revolution Medicines, Inc.
 556,392 $104,201,093
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 199,505 $99,100,118
4 ALNY
Alnylam Pharmaceuticals, Inc.
 314,512 $94,677,547
5 ONC
BeOne Medicines Ltd.
 289,735 $82,565,782
6 COGT
Cogent Biosciences, Inc.
 2,088,369 $80,819,880
7 ARGX
Argenx SE
 80,120 $74,332,932
8 ROIV
Roivant Sciences Ltd.
 1,990,510 $70,444,148

All Filings in VRDN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,370,412 1,707,698
2026-03-31 $13,921,614 711,739
2025-12-31 $24,432,249 785,098
2025-09-30 $18,563,806 860,232
2025-06-30 $12,054,576 862,273
2025-03-31 $11,868,196 880,430
2024-12-31 $14,017,506 731,221
2024-09-30 $17,058,041 749,804
2024-06-30 $9,754,950 749,804
2024-03-31 $4,902,800 280,000